-+ 0.00%
-+ 0.00%
-+ 0.00%

MARKER THERAPEUTICS AWARDED $16.2 MILLION CPRIT GRANT TO ADVANCE MT-601 IN PHASE 2 APOLLO STUDY

Reuters·11/19/2026 12:00:00

Please log in to view news